CMVPepVax to Protect HCT Recipients from Cytomegalovirus

Project: Research project

Project Details

Description

CMVPepVax to Protect HCT Recipients from Cytomegalovirus Reactivation
StatusFinished
Effective start/end date9/1/158/31/18

Funding

  • BECKMAN RES. INST. OF THE CITY OF HOPE
  • NATIONAL INSTITUTES OF HEALTH (NIH)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.